Analysis Group Welcomes New Affiliates, Announces Consultant Promotions

November 27, 2017

Analysis Group, one of the largest private economics consulting firms, announces the promotion of three consultants and welcomes six esteemed academic and industry affiliates to the firm.

“We are delighted to announce the promotions of Crystal Pike and James Signorovitch to Managing Principal, and David Mishol to Principal, and congratulate them on their accomplishments,” said CEO and Chairman Martha S. Samuelson. “We are also pleased to share the news of our affiliation with six esteemed academic and industry experts. These impressive individuals are recognized leaders in their respective fields, and underscore the breadth of our global work with their locations in the U.S., U.K., and France.”

New Affiliates

Alex Edmans, a professor of finance at London Business School, specializes in corporate finance, corporate governance, executive compensation, mergers and acquisitions (M&A), and corporate social responsibility. He has spoken at the World Economic Forum in Davos; testified in the U.K. Parliament on corporate governance; and presented to the Bank of England, the U.S. Federal Reserve, Goldman Sachs, HM Treasury, the International Monetary Fund, McKinsey, Morgan Stanley, No. 10 Policy Unit, the Organisation for Economic Co-operation and Development, the U.S. Securities and Exchange Commission, and the World Bank. Professor Edmans is Managing Editor of the Review of Finance, the leading academic finance journal in Europe, Academic Director of the LBS Centre for Corporate Governance, and serves as elected faculty representative on the LBS Governing Body. He has appeared on Bloomberg, BBC, CNBC, CNN, ITV, Reuters, and Sky News, given TEDx talks on “The Social Responsibility of Business” and “From Post-Truth to Pro-Truth,” and written for the Financial Times, Harvard Business Review, Huffington Post, and The Wall Street Journal. Professor Edmans currently serves on the steering group of The Purposeful Company, an influential U.K. consortium that proposes policy reforms to encourage companies to pursue long-run purpose over short-run profit. He is also on the responsible investment advisory committee at Royal London Asset Management. Prior to London Business School, he was a tenured professor at Wharton, where he won 14 teaching awards in six years.

Ronald C. Goodstein, an associate professor of marketing at Georgetown University McDonough School of Business, concentrates his executive teaching and consulting in the areas of customer focus, building and managing brand equity, strategic marketing management and positioning, integrated marketing communications, and consumer behavior. His work has been taught to some of the world's leading companies, including Prudential, Microsoft, Dow, CR Bard, Amoco, Shell Oil, HSBC, Credit Suisse, Lexis/Nexis, M&M Mars, Kimberly-Clark, Siemens AG, and many other Fortune 500 firms. Professor Goodstein has served as an expert witness in a number of trademark infringement, false advertising, and patent infringement matters. His experience includes testimony before the U.S. Federal Trade Commission related to consumers' likelihood of confusion in response to online search advertising In the Matter of 1-800 Contacts, Inc., and congressional expert testimony before the House Committee on Veterans' Affairs (Oversight and Investigations Subcommittee) regarding media outreach to veterans. Professor Goodstein has consulted on social media strategy with firms such as Dell, Microsoft, Fleishman/Hillard, Baker McKenzie, CR Bard, and IBM. He has written articles about the strengths and drawbacks of social marketing (e.g., Trademark Reporter, 2015) and his research on consumer behavior, building and managing brand equity, strategic marketing management and positioning, and integrated marketing communications has been published in prestigious journals, such as the Journal of Consumer Research, Journal of Marketing Research, Journal of Marketing, Journal of Public Policy & Marketing, and Pricing Strategy and Practice. Professor Goodstein was previously awarded the American Marketing Association of Washington, D.C.'s prestigious “Hall of Fame” award for his marketing teaching and practice in the metropolitan area.

Joël Peress, the AXA-INSEAD Chaired Professor in Financial Market Risk at INSEAD, is an expert in finance, specializing in capital markets, asset pricing, and portfolio theory. His theoretical and empirical research focuses on the generation and diffusion of information in financial markets, with applications to asset management, financial disclosures, media, and economic growth. His experience as an expert in securities litigation includes consulting work and the preparation of expert reports. Professor Peress has published numerous articles in leading academic journals, including The Journal of Finance, The Review of Financial Studies, The Journal of Portfolio Management, and the Journal of Economic Theory. He was twice awarded the Smith Breeden Prize for best paper published in The Journal of Finance, and was recognized in 2011 as the “Best Young Researcher in Finance,” a title awarded by the Institut Louis-Bachelier and the Institut Europlace de Finance, two foundations that promote financial research. Professor Peress serves as coeditor of The Review of Finance. He also served as a visiting scholar at Princeton University's Bendheim Center for Finance in 2006, the London School of Economics in 2007–2008, and University of Southern California's Marshall School of Business in 2013–2014. An accomplished teacher, he was twice awarded the Dean's Commendation for Excellence in M.B.A. Teaching. While working on his Ph.D. in economics at the University of Chicago, Professor Peress worked at Lehman Brothers in both the fixed-income research and emerging market desk groups based in London and New York, respectively.

Jeffrey T. Prince, the Harold A. Poling Chair in Strategic Management, and Professor and Chairperson of Business Economics and Public Policy at the Kelley School of Business at Indiana University, focuses his research in industrial organization and applied econometrics on technology markets and telecommunications. He has published research on dynamic demand for computers, Internet adoption and usage, the inception of online/offline product competition, and telecom bundling. Professor Prince has also studied topics such as household-level risk aversion, airline quality competition, and regulation in health care and real estate markets. His research has appeared in top journals in both economics and management, including the American Economic Review, the International Economic Review, The Journal of Industrial Economics, the Journal of Economics and Management Strategy, the International Journal of Industrial Organization, Management Science, and the Academy of Management Journal. Professor Prince is currently a coeditor at the Journal of Economics and Management Strategy, and is on the board of editors at Information Economics and Policy.

Gary H. Stern is an expert in the areas of bank regulation, monetary policy, and macroeconomics, and has over 40 years of experience in economics and banking. Dr. Stern served as the president and chief executive officer of the Federal Reserve Bank of Minneapolis for 24 years. During this tenure, he was chairman of the Federal Reserve System's Financial Services Policy Committee and oversaw substantial changes to the Federal Reserve's role in the nation's payments system. Earlier in his career, he spent seven years at the Federal Reserve Bank of New York. He has also held faculty positions at Columbia University, New York University, and Washington University in St. Louis, among others. Currently, Dr. Stern serves as a board member of S&P Ratings; E*TRADE Financial Corporation; Ambac Assurance Corporation; the Council for Economic Education (CEE), where he is former president of the board; Hamline University; and the Depository Trust and Clearing Corporation, where he is lead director and chair of the Board Risk Committee. He also is a member of the Federal Deposit Insurance Corporation's (FDIC's) Systemic Resolution Advisory Committee. Dr. Stern has been widely published and quoted, and along with Minneapolis Fed Senior Vice President Ron Feldman, he is the coauthor of Too Big to Fail: The Hazards of Bank Bailouts.

Joseph Willett has over 25 years of experience in financial and executive management. He is the former chief operating officer of Merrill Lynch Europe, Middle East & Africa, responsible for the firm's business activities in the region, including private client, institutional investor, investment banking, securities trading, and asset management. Prior to that, he served as senior vice president and chief financial officer of Merrill Lynch & Co., Inc., responsible for the company's audit, controller, tax, credit, investor relations, and treasury functions. Prior to joining Merrill Lynch, Mr. Willett served six years with Chase Manhattan Bank, where he was vice president in the Chase financial policy division. Since 2002, he has served as a director of the Marsico Investment Fund and chair of its audit committee.

New Managing Principals

Crystal Pike applies her expertise in health economics, statistics, and large administrative claims and transaction-level databases to help resolve complex litigation and strategic business questions in a variety of contexts, including matters involving the False Claims Act, Anti-Kickback Statute, and Controlled Substance Act. She has performed economic analyses and presented findings to U.S. Attorney's Office investigators in numerous cases involving allegations of off-label promotion, kickback, and pricing issues. Ms. Pike also applies economic theory and empirical estimation methods in a variety of product liability, breach of contract, intellectual property, and transfer-pricing engagements. She has extensive experience in developing flexible damages models for real-time use in high-stakes negotiations. Ms. Pike has been instrumental in developing bespoke suspicious order monitoring programs; building internal analytical programs to assess the risk of theft or diversion; and assisting manufacturers, wholesalers, and pharmacies in responding to government investigations and/or lawsuits related to controlled substance distribution and dispensing. She has managed a range of health care cases involving analysis of future lost profits; economic analysis of physician payment structures under capitation; studies of the cost effectiveness, budget impacts, and direct and indirect costs of illness associated with a variety of diseases; and pricing analyses for large multinational corporations across numerous industries. Ms. Pike has published numerous articles on related topics in health care economics and clinical journals.

James Signorovitch advises life sciences companies on data analytics for business critical research and decision-making. He has broad experience leading the strategic development and implementation of analytics across the product lifecycle, from early phase clinical studies to market access and real-world evidence generation. Dr. Signorovitch's practice areas span trial design, multi-stakeholder collaborations, natural history studies, regulatory interactions, health economic modeling, global reimbursement submissions, policy evaluation, real-world evidence development, individualized medicine, predictive analytics, and due diligence for acquisitions. He has particular expertise in developing and applying new methodologies to address healthcare research challenges, and in designing analytics platforms to enhance collaborative research and decision-making. Dr. Signorovitch's work has been used to inform clinical regulators and health care payers in U.S. and global markets, published in peer-reviewed journals, and presented at clinical and economic research conferences. Prior to joining Analysis Group, Dr. Signorovitch was a research fellow at the Harvard-MIT Division of Health Sciences and Technology.

New Principal

Based in our London office, David N. Mishol is an economist who specializes in competition, econometrics, microeconomic theory, statistics, securities, health care, and pharmacoeconomics. He has provided consulting support to counsel throughout many phases of litigation, including preparation of expert deposition and trial testimony; development, presentation, and review of pretrial discovery; and critique of analyses of opposing experts. He has served as an expert witness and worked with leading academic scholars, providing economic and damages analysis on matters involving cartels, mergers, and other cases involving market definition issues in a variety of industries; economic, financial, and quantitative analyses related to allegations of securities fraud in 10b-5, ERISA, and mortgage-backed securities matters; and economic, quantitative, and damages analyses in the pharmaceutical industry. Outside of litigation, Dr. Mishol has used sophisticated econometric modeling techniques to help major pharmaceutical companies make product entry decisions by assessing the impact of market factors such as product quality, pricing, patent expiration, and regulatory policy on the demand for prescription pharmaceuticals. His work also includes econometric analysis of the spending experience of private-pay and Medicare patients across the United States, examining direct usage and cost impacts related to the supply of specific technologies, such as diagnostic imaging, cardiac care, newborn care for at-risk infants, and cancer care.